US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Phio Pharmaceuticals

1.26

0.0000

Post-market: 1.280.0200+1.59%19:54 EDT

Volume:290.07K

Turnover:370.18K

Market Cap:14.64M

PE:-0.87

High:1.31

Open:1.28

Low:1.22

Close:1.26

52wk High:4.19

52wk Low:0.8127

Shares:11.62M

Float Shares:11.55M

Volume Ratio:0.83

T/O Rate:2.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4535

EPS(LYR):-9.0798

ROE:-69.95%

ROA:-42.33%

PB:0.73

PE(LYR):-0.14

Loading ...

Overview Company News Filings

Phio Pharmaceuticals Corp - Favorable Safety and Tolerability at All Dose Escalations - SEC Filing

THOMSON REUTERS

Phio Pharmaceuticals Corp: Safety Data Through Extended Follow-up Period Is Expected to Be Reported in Q2 of 2026

THOMSON REUTERS

Phio Pharmaceuticals Reports 70% Response Rate in PH-762 Skin Cancer Trial

Phio Pharmaceuticals Showcases INTASYL siRNA Cancer Therapy at Sidoti Micro-Cap Virtual Investor Conference

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares

Phio Pharmaceuticals Corp - No Dose-Limiting Toxicities in Ph-762 Trial - SEC Filing

THOMSON REUTERS

Phio Pharmaceuticals Corp - Ph-762 Has Been Well Tolerated in All Enrolled Patients in Each Escalating Dose Cohort

THOMSON REUTERS

Phio Pharmaceuticals Corp - Initiatives Continuing to Advance Delivery of Commercially Viable Drug Product in 2026

THOMSON REUTERS

Phio Pharmaceuticals Announces FDA Acceptance of Nonclinical Study Design for PH-762

Phio Pharmaceuticals Completes Enrollment for PH-762 Trial

Phio Pharmaceuticals Completes Phase 1b Enrollment for PH-762 Skin Cancer Trial

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares

BRIEF-Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing

Phio Pharmaceuticals files to sell 11.76M shares of common stock for holders

Phio Pharmaceuticals Corp Files for Offering of up to 11.8 Mln Common Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS

Phio Pharmaceuticals CEO Robert J. Bitterman Acquires Common Shares

Phio Pharmaceuticals to Present INTASYL siRNA Technology at Advanced Therapies USA Congress

Phio Pharma Q3 EPS $(0.44) Misses $(0.40) Estimate

Phio Pharmaceuticals Reports Positive PH-762 Skin Cancer Trial Results and Extends Cash Runway Into 2027

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PHIO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHIO\",,,,,undefined,":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":1.26,"timestamp":1774641600000,"preClose":1.26,"halted":0,"volume":290074,"hourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.26,"latestTime":"19:54 EDT","volume":4200,"amount":5295.8733,"timestamp":1774655693443,"change":0.02,"changeRate":0.015873,"amplitude":0.046667},"delay":0,"changeRate":0,"floatShares":11548100,"shares":11617300,"eps":-1.453538,"marketStatus":"Market Closed","change":0,"latestTime":"03-27 16:00:00 EDT","open":1.28,"high":1.3149,"low":1.22,"amount":370177.064878,"amplitude":0.075317,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.453538,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.32,"preClose":1.26,"latestTime":"09:28 EDT","volume":24024,"amount":32162.2885584,"timestamp":1774618122420,"change":0.06,"changeRate":0.047619,"amplitude":0.047619},"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.26,"latestTime":"19:54 EDT","volume":4200,"amount":5295.8733,"timestamp":1774655693443,"change":0.02,"changeRate":0.015873,"amplitude":0.046667},"volumeRatio":0.831851,"impliedVol":2.2612,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHIO\",,,,,undefined,":{"symbol":"PHIO","floatShares":11548100,"roa":"-42.33%","roe":"-69.95%","lyrEps":-9.079757,"volumeRatio":0.831851,"shares":11617300,"dividePrice":0,"high":1.3149,"amplitude":0.075317,"preClose":1.26,"low":1.22,"week52Low":0.8127,"pbRate":"0.73","week52High":4.1899,"institutionHeld":0,"latestPrice":1.26,"eps":-1.453538,"divideRate":0,"volume":290074,"delay":0,"ttmEps":-1.453538,"open":1.28,"prevYearClose":1.05,"prevWeekClose":1.22,"prevMonthClose":1.14,"prevQuarterClose":1.05,"fiveDayClose":1.22,"twentyDayClose":1.14,"sixtyDayClose":1.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-05","symbol":"PHIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2025-11-13","symbol":"PHIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2025-08-14","symbol":"PHIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2025-05-15","symbol":"PHIO","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2025-03-31","symbol":"PHIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1740024000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHIO","date":"2026-03-27","current":-0.86685,"percent":0.200326,"low":-4.308554,"twenty":-1.684948,"median":-0.776088,"eighty":-0.326811,"high":-0.115258,"avg":-1.047068,"sd":0.860634,"marketCap":14637735},"quantilePoints":[{"date":"2021-04-01","current":-4.231616,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":37212827},{"date":"2021-04-09","current":-4.216228,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":37077508},{"date":"2021-04-16","current":-3.523782,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":30988135},{"date":"2021-04-23","current":-3.585332,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31529413},{"date":"2021-04-30","current":-3.5552,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31264430},{"date":"2021-05-07","current":-4.109257,"twenty":-1.498848,"median":-1.169531,"eighty":-0.754151,"marketCap":36136808},{"date":"2021-05-14","current":-2.624434,"twenty":-1.499955,"median":-1.169531,"eighty":-0.754151,"marketCap":25850675},{"date":"2021-05-21","current":-2.926725,"twenty":-1.501287,"median":-1.169531,"eighty":-0.754151,"marketCap":28828240},{"date":"2021-05-28","current":-3.050389,"twenty":-1.503829,"median":-1.169531,"eighty":-0.754151,"marketCap":30046334},{"date":"2021-06-04","current":-2.844282,"twenty":-1.504533,"median":-1.169531,"eighty":-0.754151,"marketCap":28016176},{"date":"2021-06-11","current":-3.036649,"twenty":-1.506728,"median":-1.169531,"eighty":-0.754151,"marketCap":29910991},{"date":"2021-06-18","current":-3.022908,"twenty":-1.511311,"median":-1.169531,"eighty":-0.754151,"marketCap":29775647},{"date":"2021-06-25","current":-3.325199,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":32753212},{"date":"2021-07-02","current":-2.967946,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":29234272},{"date":"2021-07-09","current":-2.858022,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":28151520},{"date":"2021-07-16","current":-2.50077,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24632580},{"date":"2021-07-23","current":-2.583213,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":25444644},{"date":"2021-07-30","current":-2.473289,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24361893},{"date":"2021-08-06","current":-2.473289,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24361893},{"date":"2021-08-13","current":-2.142581,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":23279142},{"date":"2021-08-20","current":-2.10521,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":22873111},{"date":"2021-08-27","current":-2.379261,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":25850675},{"date":"2021-09-03","current":-2.528744,"twenty":-1.513652,"median":-1.169531,"eighty":-0.754151,"marketCap":27474801},{"date":"2021-09-10","current":-2.553658,"twenty":-1.517656,"median":-1.169531,"eighty":-0.754151,"marketCap":27745489},{"date":"2021-09-17","current":-2.840165,"twenty":-1.535231,"median":-1.169531,"eighty":-0.754151,"marketCap":30858397},{"date":"2021-09-24","current":-2.678226,"twenty":-1.55235,"median":-1.169531,"eighty":-0.754151,"marketCap":29098928},{"date":"2021-10-01","current":-2.478916,"twenty":-1.568375,"median":-1.169531,"eighty":-0.754151,"marketCap":26933426},{"date":"2021-10-08","current":-2.279606,"twenty":-1.575639,"median":-1.177333,"eighty":-0.754151,"marketCap":24767924},{"date":"2021-10-15","current":-2.080297,"twenty":-1.592553,"median":-1.179943,"eighty":-0.754151,"marketCap":22602423},{"date":"2021-10-22","current":-2.030469,"twenty":-1.605485,"median":-1.187834,"eighty":-0.757627,"marketCap":22061047},{"date":"2021-10-29","current":-2.092754,"twenty":-1.626655,"median":-1.191091,"eighty":-0.757651,"marketCap":22737767},{"date":"2021-11-05","current":-2.130124,"twenty":-1.639611,"median":-1.196448,"eighty":-0.757891,"marketCap":23143798},{"date":"2021-11-12","current":-1.727879,"twenty":-1.652657,"median":-1.202967,"eighty":-0.759558,"marketCap":21249455},{"date":"2021-11-19","current":-1.507767,"twenty":-1.654895,"median":-1.210405,"eighty":-0.760343,"marketCap":18542518},{"date":"2021-11-26","current":-1.529778,"twenty":-1.652657,"median":-1.212029,"eighty":-0.760343,"marketCap":18813211},{"date":"2021-12-03","current":-1.298661,"twenty":-1.652657,"median":-1.2135,"eighty":-0.760343,"marketCap":15970928},{"date":"2021-12-10","current":-1.353689,"twenty":-1.652657,"median":-1.217439,"eighty":-0.760343,"marketCap":16647662},{"date":"2021-12-17","current":-1.287655,"twenty":-1.652657,"median":-1.227086,"eighty":-0.761524,"marketCap":15835581},{"date":"2021-12-23","current":-1.298661,"twenty":-1.652657,"median":-1.228561,"eighty":-0.763642,"marketCap":15970928},{"date":"2021-12-31","current":-1.10056,"twenty":-1.652657,"median":-1.228561,"eighty":-0.77102,"marketCap":13534684},{"date":"2022-01-07","current":-1.063471,"twenty":-1.652486,"median":-1.228561,"eighty":-0.771783,"marketCap":13078565},{"date":"2022-01-14","current":-0.973005,"twenty":-1.652486,"median":-1.228561,"eighty":-0.773446,"marketCap":11966015},{"date":"2022-01-21","current":-0.946812,"twenty":-1.652486,"median":-1.228561,"eighty":-0.776821,"marketCap":11643889},{"date":"2022-01-28","current":-0.871643,"twenty":-1.652486,"median":-1.228561,"eighty":-0.781639,"marketCap":10719469},{"date":"2022-02-04","current":-0.985881,"twenty":-1.652486,"median":-1.228561,"eighty":-0.784351,"marketCap":12124370},{"date":"2022-02-11","current":-0.986432,"twenty":-1.652316,"median":-1.228561,"eighty":-0.78546,"marketCap":12131138},{"date":"2022-02-18","current":-0.917427,"twenty":-1.652316,"median":-1.228561,"eighty":-0.790609,"marketCap":11282513},{"date":"2022-02-25","current":-0.928542,"twenty":-1.652316,"median":-1.228561,"eighty":-0.794492,"marketCap":11419214},{"date":"2022-03-04","current":-0.891013,"twenty":-1.652316,"median":-1.228561,"eighty":-0.797055,"marketCap":10957680},{"date":"2022-03-11","current":-0.847211,"twenty":-1.652316,"median":-1.228561,"eighty":-0.798197,"marketCap":10419000},{"date":"2022-03-18","current":-0.934375,"twenty":-1.652316,"median":-1.228561,"eighty":-0.802126,"marketCap":11490947},{"date":"2022-03-25","current":-0.921076,"twenty":-1.652316,"median":-1.228561,"eighty":-0.806184,"marketCap":12238333},{"date":"2022-04-01","current":-0.890312,"twenty":-1.646585,"median":-1.228151,"eighty":-0.808371,"marketCap":11829577},{"date":"2022-04-08","current":-2.39386,"twenty":-1.639396,"median":-1.224535,"eighty":-0.808371,"marketCap":31807215},{"date":"2022-04-14","current":-1.21221,"twenty":-1.639396,"median":-1.220432,"eighty":-0.808371,"marketCap":16106631},{"date":"2022-04-22","current":-1.283516,"twenty":-1.639396,"median":-1.220432,"eighty":-0.808371,"marketCap":17054081},{"date":"2022-04-29","current":-0.855881,"twenty":-1.639396,"median":-1.214647,"eighty":-0.808371,"marketCap":11372094},{"date":"2022-05-06","current":-0.870346,"twenty":-1.639396,"median":-1.212174,"eighty":-0.808371,"marketCap":11564291},{"date":"2022-05-13","current":-0.771725,"twenty":-1.639396,"median":-1.212137,"eighty":-0.803488,"marketCap":9663542},{"date":"2022-05-20","current":-0.723513,"twenty":-1.639396,"median":-1.206863,"eighty":-0.801113,"marketCap":9059827},{"date":"2022-05-27","current":-0.796268,"twenty":-1.639396,"median":-1.201104,"eighty":-0.797537,"marketCap":9970863},{"date":"2022-06-03","current":-0.839026,"twenty":-1.639396,"median":-1.198734,"eighty":-0.797167,"marketCap":10506284},{"date":"2022-06-10","current":-0.780888,"twenty":-1.639396,"median":-1.193559,"eighty":-0.796536,"marketCap":9778275},{"date":"2022-06-17","current":-0.729621,"twenty":-1.639396,"median":-1.184786,"eighty":-0.793918,"marketCap":9136315},{"date":"2022-06-24","current":-0.740965,"twenty":-1.639504,"median":-1.17781,"eighty":-0.790818,"marketCap":9278366},{"date":"2022-07-01","current":-0.767253,"twenty":-1.639504,"median":-1.17061,"eighty":-0.788511,"marketCap":9607541},{"date":"2022-07-08","current":-0.801831,"twenty":-1.639504,"median":-1.167786,"eighty":-0.787642,"marketCap":10040522},{"date":"2022-07-15","current":-0.771399,"twenty":-1.639504,"median":-1.158325,"eighty":-0.786964,"marketCap":9659458},{"date":"2022-07-22","current":-0.784051,"twenty":-1.639504,"median":-1.151485,"eighty":-0.78508,"marketCap":9817885},{"date":"2022-07-29","current":-0.780015,"twenty":-1.639504,"median":-1.145238,"eighty":-0.783179,"marketCap":9767348},{"date":"2022-08-05","current":-0.785578,"twenty":-1.639504,"median":-1.142726,"eighty":-0.781191,"marketCap":9837007},{"date":"2022-08-12","current":-0.817469,"twenty":-1.639504,"median":-1.133577,"eighty":-0.781191,"marketCap":10108816},{"date":"2022-08-19","current":-0.795488,"twenty":-1.639504,"median":-1.124069,"eighty":-0.781191,"marketCap":9837007},{"date":"2022-08-26","current":-0.763346,"twenty":-1.639504,"median":-1.118863,"eighty":-0.778622,"marketCap":9439539},{"date":"2022-09-02","current":-0.760806,"twenty":-1.639504,"median":-1.112659,"eighty":-0.776493,"marketCap":9408124},{"date":"2022-09-09","current":-0.793831,"twenty":-1.639504,"median":-1.110534,"eighty":-0.775608,"marketCap":9816519},{"date":"2022-09-16","current":-0.751086,"twenty":-1.639504,"median":-1.101669,"eighty":-0.77548,"marketCap":9287927},{"date":"2022-09-23","current":-0.678959,"twenty":-1.639504,"median":-1.09706,"eighty":-0.773926,"marketCap":8396012},{"date":"2022-09-30","current":-0.631022,"twenty":-1.639504,"median":-1.091535,"eighty":-0.773184,"marketCap":7803224},{"date":"2022-10-07","current":-0.613019,"twenty":-1.639504,"median":-1.084943,"eighty":-0.772177,"marketCap":7580587},{"date":"2022-10-14","current":-0.61578,"twenty":-1.639504,"median":-1.078622,"eighty":-0.771783,"marketCap":7614734},{"date":"2022-10-21","current":-0.641847,"twenty":-1.639504,"median":-1.066994,"eighty":-0.771127,"marketCap":7937079},{"date":"2022-10-28","current":-0.646376,"twenty":-1.639504,"median":-1.055575,"eighty":-0.767034,"marketCap":7993080},{"date":"2022-11-04","current":-0.619646,"twenty":-1.639504,"median":-1.037137,"eighty":-0.763737,"marketCap":7662539},{"date":"2022-11-11","current":-0.53798,"twenty":-1.639504,"median":-1.032527,"eighty":-0.7629,"marketCap":6563358},{"date":"2022-11-18","current":-0.44813,"twenty":-1.639504,"median":-1.023521,"eighty":-0.761465,"marketCap":5467186},{"date":"2022-11-25","current":-0.45362,"twenty":-1.639504,"median":-1.020329,"eighty":-0.759288,"marketCap":5534159},{"date":"2022-12-02","current":-0.445105,"twenty":-1.631759,"median":-1.011325,"eighty":-0.755853,"marketCap":5430283},{"date":"2022-12-09","current":-0.439027,"twenty":-1.631759,"median":-0.999192,"eighty":-0.753074,"marketCap":5356134},{"date":"2022-12-16","current":-0.426844,"twenty":-1.631759,"median":-0.992495,"eighty":-0.75098,"marketCap":5207495},{"date":"2022-12-23","current":-0.401525,"twenty":-1.631759,"median":-0.985881,"eighty":-0.747725,"marketCap":4898599},{"date":"2022-12-30","current":-0.416761,"twenty":-1.631759,"median":-0.979938,"eighty":-0.745379,"marketCap":5084483},{"date":"2023-01-06","current":-0.683398,"twenty":-1.631759,"median":-0.977213,"eighty":-0.742198,"marketCap":8337460},{"date":"2023-01-13","current":-0.60363,"twenty":-1.631759,"median":-0.977213,"eighty":-0.740355,"marketCap":7364287},{"date":"2023-01-20","current":-0.592652,"twenty":-1.631759,"median":-0.977213,"eighty":-0.737547,"marketCap":7230355},{"date":"2023-01-27","current":-0.581635,"twenty":-1.631759,"median":-0.977213,"eighty":-0.734106,"marketCap":7095951},{"date":"2023-02-03","current":-0.616179,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":7517380},{"date":"2023-02-10","current":-0.515331,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":6287035},{"date":"2023-02-17","current":-0.489209,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":5968344},{"date":"2023-02-24","current":-0.480806,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":5865834},{"date":"2023-03-03","current":-0.560162,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":6833982},{"date":"2023-03-10","current":-0.516031,"twenty":-1.631759,"median":-0.977213,"eighty":-0.728426,"marketCap":6295578},{"date":"2023-03-17","current":-0.535889,"twenty":-1.631759,"median":-0.977068,"eighty":-0.726171,"marketCap":6537842},{"date":"2023-03-24","current":-0.572334,"twenty":-1.631759,"median":-0.977068,"eighty":-0.71795,"marketCap":6570398},{"date":"2023-03-31","current":-0.563264,"twenty":-1.629249,"median":-0.975604,"eighty":-0.717167,"marketCap":6466270},{"date":"2023-04-06","current":-0.5793,"twenty":-1.629249,"median":-0.975604,"eighty":-0.714469,"marketCap":6650363},{"date":"2023-04-14","current":-0.505134,"twenty":-1.631759,"median":-0.973005,"eighty":-0.711472,"marketCap":5798933},{"date":"2023-04-21","current":-0.539966,"twenty":-1.631759,"median":-0.973005,"eighty":-0.704091,"marketCap":6198807},{"date":"2023-04-28","current":-0.423323,"twenty":-1.631759,"median":-0.973005,"eighty":-0.701367,"marketCap":4859744},{"date":"2023-05-05","current":-0.509822,"twenty":-1.631759,"median":-0.973005,"eighty":-0.697146,"marketCap":5852757},{"date":"2023-05-12","current":-0.510477,"twenty":-1.631759,"median":-0.9686,"eighty":-0.690766,"marketCap":5860280},{"date":"2023-05-19","current":-0.610776,"twenty":-1.631759,"median":-0.967994,"eighty":-0.681773,"marketCap":7598053},{"date":"2023-05-26","current":-0.454756,"twenty":-1.631759,"median":-0.965521,"eighty":-0.67868,"marketCap":5657164},{"date":"2023-06-02","current":-0.408797,"twenty":-1.631759,"median":-0.96266,"eighty":-0.676522,"marketCap":5085429},{"date":"2023-06-09","current":-0.431758,"twenty":-1.631759,"median":-0.958147,"eighty":-0.664276,"marketCap":5371071},{"date":"2023-06-16","current":-0.456909,"twenty":-1.631759,"median":-0.954712,"eighty":-0.657282,"marketCap":5683949},{"date":"2023-06-23","current":-0.419183,"twenty":-1.634269,"median":-0.944146,"eighty":-0.654729,"marketCap":5214633},{"date":"2023-06-30","current":-0.392634,"twenty":-1.636779,"median":-0.938527,"eighty":-0.648646,"marketCap":4884372},{"date":"2023-07-07","current":-0.419183,"twenty":-1.636779,"median":-0.938527,"eighty":-0.644655,"marketCap":5214633},{"date":"2023-07-14","current":-0.38984,"twenty":-1.636779,"median":-0.937013,"eighty":-0.639638,"marketCap":4849608},{"date":"2023-07-21","current":-0.370977,"twenty":-1.636779,"median":-0.937013,"eighty":-0.633655,"marketCap":4614950},{"date":"2023-07-28","current":-0.375867,"twenty":-1.636779,"median":-0.937013,"eighty":-0.631022,"marketCap":4675787},{"date":"2023-08-04","current":-0.353511,"twenty":-1.639289,"median":-0.93777,"eighty":-0.629587,"marketCap":4397673},{"date":"2023-08-11","current":-0.318579,"twenty":-1.639289,"median":-0.93777,"eighty":-0.624064,"marketCap":3963121},{"date":"2023-08-18","current":-0.406633,"twenty":-1.639289,"median":-0.93777,"eighty":-0.621893,"marketCap":5065831},{"date":"2023-08-25","current":-0.413767,"twenty":-1.639289,"median":-0.93777,"eighty":-0.619457,"marketCap":5154705},{"date":"2023-09-01","current":-0.379881,"twenty":-1.639289,"median":-0.93777,"eighty":-0.610776,"marketCap":4732553},{"date":"2023-09-08","current":-0.401282,"twenty":-1.639396,"median":-0.938527,"eighty":-0.608865,"marketCap":4999176},{"date":"2023-09-15","current":-0.311217,"twenty":-1.639504,"median":-0.939799,"eighty":-0.604931,"marketCap":3877138},{"date":"2023-09-22","current":-0.249687,"twenty":-1.639504,"median":-0.939799,"eighty":-0.602435,"marketCap":3110598},{"date":"2023-09-29","current":-0.262171,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3266128},{"date":"2023-10-06","current":-0.260388,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3243909},{"date":"2023-10-13","current":-0.313892,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3910466},{"date":"2023-10-20","current":-0.244336,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3043942},{"date":"2023-10-27","current":-0.226502,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2821757},{"date":"2023-11-03","current":-0.222578,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2772876},{"date":"2023-11-10","current":-0.181915,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2266293},{"date":"2023-11-17","current":-0.205332,"twenty":-1.639826,"median":-0.942079,"eighty":-0.597918,"marketCap":2394578},{"date":"2023-11-24","current":-0.196951,"twenty":-1.639826,"median":-0.942079,"eighty":-0.591142,"marketCap":2296840},{"date":"2023-12-01","current":-0.229112,"twenty":-1.639826,"median":-0.942079,"eighty":-0.581635,"marketCap":2671909},{"date":"2023-12-08","current":-0.19276,"twenty":-1.639719,"median":-0.941575,"eighty":-0.578835,"marketCap":2247971},{"date":"2023-12-15","current":-0.155046,"twenty":-1.639719,"median":-0.941575,"eighty":-0.573898,"marketCap":1808150},{"date":"2023-12-22","current":-0.16106,"twenty":-1.639719,"median":-0.941575,"eighty":-0.569388,"marketCap":1878277},{"date":"2023-12-29","current":-0.160075,"twenty":-1.639826,"median":-0.942079,"eighty":-0.563264,"marketCap":1866793},{"date":"2024-01-05","current":-0.159656,"twenty":-1.640714,"median":-0.944146,"eighty":-0.559038,"marketCap":1861906},{"date":"2024-01-12","current":-0.146644,"twenty":-1.640714,"median":-0.944146,"eighty":-0.544651,"marketCap":1710168},{"date":"2024-01-19","current":-0.138285,"twenty":-1.641601,"median":-0.946213,"eighty":-0.539172,"marketCap":1612675},{"date":"2024-01-26","current":-0.125713,"twenty":-1.640714,"median":-0.944146,"eighty":-0.534718,"marketCap":1466068},{"date":"2024-02-02","current":-0.127599,"twenty":-1.640714,"median":-0.944146,"eighty":-0.52585,"marketCap":1488059},{"date":"2024-02-09","current":-0.127348,"twenty":-1.640714,"median":-0.944146,"eighty":-0.522459,"marketCap":1485127},{"date":"2024-02-16","current":-0.136189,"twenty":-1.640714,"median":-0.944146,"eighty":-0.51385,"marketCap":1588240},{"date":"2024-02-23","current":-0.178077,"twenty":-1.640714,"median":-0.944146,"eighty":-0.512362,"marketCap":2076736},{"date":"2024-03-01","current":-0.226284,"twenty":-1.639826,"median":-0.942079,"eighty":-0.508511,"marketCap":2638922},{"date":"2024-03-08","current":-0.184798,"twenty":-1.639826,"median":-0.942079,"eighty":-0.503269,"marketCap":2155120},{"date":"2024-03-15","current":-0.197244,"twenty":-1.639826,"median":-0.935928,"eighty":-0.492183,"marketCap":2300261},{"date":"2024-03-22","current":-0.175999,"twenty":-1.639826,"median":-0.928542,"eighty":-0.488621,"marketCap":2052495},{"date":"2024-03-28","current":-0.152134,"twenty":-1.639826,"median":-0.921076,"eighty":-0.486408,"marketCap":1774186},{"date":"2024-04-05","current":-0.156456,"twenty":-1.640714,"median":-0.916562,"eighty":-0.480806,"marketCap":1693797},{"date":"2024-04-12","current":-0.296683,"twenty":-1.640714,"median":-0.91096,"eighty":-0.469768,"marketCap":3211894},{"date":"2024-04-19","current":-0.270514,"twenty":-1.640714,"median":-0.906077,"eighty":-0.458759,"marketCap":2928586},{"date":"2024-04-26","current":-0.29944,"twenty":-1.639826,"median":-0.902569,"eighty":-0.45362,"marketCap":3241740},{"date":"2024-05-03","current":-0.329002,"twenty":-1.639826,"median":-0.896424,"eighty":-0.44813,"marketCap":3561781},{"date":"2024-05-10","current":-0.326585,"twenty":-1.639826,"median":-0.890312,"eighty":-0.445105,"marketCap":3535609},{"date":"2024-05-17","current":-0.358601,"twenty":-1.639826,"median":-0.880558,"eighty":-0.440142,"marketCap":3362961},{"date":"2024-05-24","current":-0.375934,"twenty":-1.639826,"median":-0.869368,"eighty":-0.436591,"marketCap":3525507},{"date":"2024-05-31","current":-0.368247,"twenty":-1.639826,"median":-0.863934,"eighty":-0.431758,"marketCap":3453417},{"date":"2024-06-07","current":-0.367218,"twenty":-1.639826,"median":-0.848175,"eighty":-0.425948,"marketCap":3443775},{"date":"2024-06-14","current":-0.357426,"twenty":-1.640714,"median":-0.843753,"eighty":-0.421762,"marketCap":3351941},{"date":"2024-06-21","current":-0.349053,"twenty":-1.641601,"median":-0.832901,"eighty":-0.419183,"marketCap":3273422},{"date":"2024-06-28","current":-0.337449,"twenty":-1.644264,"median":-0.825843,"eighty":-0.417785,"marketCap":3164595},{"date":"2024-07-05","current":-0.284373,"twenty":-1.644264,"median":-0.821822,"eighty":-0.414991,"marketCap":2666854},{"date":"2024-07-12","current":-0.317983,"twenty":-1.644264,"median":-0.816685,"eighty":-0.411983,"marketCap":2982048},{"date":"2024-07-15","current":-0.274733,"twenty":-1.644264,"median":-0.812746,"eighty":-0.410799,"marketCap":2576449},{"date":"2024-08-02","current":-0.161304,"twenty":-1.655347,"median":-0.803629,"eighty":-0.407754,"marketCap":1512707},{"date":"2024-08-09","current":-0.143079,"twenty":-1.655347,"median":-0.80079,"eighty":-0.40521,"marketCap":1341794},{"date":"2024-08-16","current":-0.151733,"twenty":-1.655347,"median":-0.798197,"eighty":-0.402675,"marketCap":1316285},{"date":"2024-08-23","current":-0.303609,"twenty":-1.655347,"median":-0.796603,"eighty":-0.395988,"marketCap":2633806},{"date":"2024-08-30","current":-0.261937,"twenty":-1.655347,"median":-0.793831,"eighty":-0.391029,"marketCap":2272303},{"date":"2024-09-06","current":-0.260945,"twenty":-1.655347,"median":-0.789855,"eighty":-0.385648,"marketCap":2263696},{"date":"2024-09-13","current":-0.287734,"twenty":-1.655347,"median":-0.786887,"eighty":-0.381456,"marketCap":2496090},{"date":"2024-09-20","current":-0.352226,"twenty":-1.655347,"median":-0.781191,"eighty":-0.37873,"marketCap":3055559},{"date":"2024-09-27","current":-0.35421,"twenty":-1.655347,"median":-0.779362,"eighty":-0.374682,"marketCap":3072773},{"date":"2024-10-04","current":-0.313531,"twenty":-1.655347,"median":-0.775543,"eighty":-0.372417,"marketCap":2719878},{"date":"2024-10-11","current":-0.253007,"twenty":-1.655347,"median":-0.773907,"eighty":-0.36763,"marketCap":2194838},{"date":"2024-10-18","current":-0.262929,"twenty":-1.655347,"median":-0.773508,"eighty":-0.363792,"marketCap":2280910},{"date":"2024-10-25","current":-0.293687,"twenty":-1.655347,"median":-0.773177,"eighty":-0.357426,"marketCap":2547734},{"date":"2024-10-31","current":-0.312538,"twenty":-1.655347,"median":-0.772052,"eighty":-0.353511,"marketCap":2711271},{"date":"2024-11-08","current":-0.32246,"twenty":-1.65613,"median":-0.770744,"eighty":-0.35155,"marketCap":2797343},{"date":"2024-11-15","current":-0.221257,"twenty":-1.65613,"median":-0.76436,"eighty":-0.347708,"marketCap":1919407},{"date":"2024-11-22","current":-0.29352,"twenty":-1.65613,"median":-0.76436,"eighty":-0.344977,"marketCap":2177624},{"date":"2024-11-29","current":-0.386871,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":2870195},{"date":"2024-12-06","current":-0.385449,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":2859643},{"date":"2024-12-13","current":-0.408362,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":3029639},{"date":"2024-12-20","current":-0.247484,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339311,"marketCap":1836081},{"date":"2024-12-27","current":-0.297265,"twenty":-1.65613,"median":-0.76436,"eighty":-0.337364,"marketCap":2205407},{"date":"2025-01-03","current":-0.270241,"twenty":-1.65613,"median":-0.763489,"eighty":-0.332534,"marketCap":2004916},{"date":"2025-01-10","current":-0.240372,"twenty":-1.656913,"median":-0.762021,"eighty":-0.326962,"marketCap":1783320},{"date":"2025-01-17","current":-0.831105,"twenty":-1.656913,"median":-0.760806,"eighty":-0.326585,"marketCap":6165966},{"date":"2025-01-24","current":-0.881902,"twenty":-1.656913,"median":-0.760806,"eighty":-0.326585,"marketCap":6542829},{"date":"2025-01-31","current":-0.836676,"twenty":-1.656913,"median":-0.7613,"eighty":-0.326585,"marketCap":6207299},{"date":"2025-02-07","current":-0.931978,"twenty":-1.656913,"median":-0.762021,"eighty":-0.326585,"marketCap":6914344},{"date":"2025-02-14","current":-0.821793,"twenty":-1.656913,"median":-0.763435,"eighty":-0.326962,"marketCap":6096884},{"date":"2025-02-21","current":-0.789656,"twenty":-1.656913,"median":-0.765835,"eighty":-0.326962,"marketCap":5858459},{"date":"2025-02-28","current":-0.920729,"twenty":-1.656913,"median":-0.768837,"eighty":-0.326962,"marketCap":6830892},{"date":"2025-03-07","current":-0.862782,"twenty":-1.657245,"median":-0.771897,"eighty":-0.326887,"marketCap":6400976},{"date":"2025-03-14","current":-0.856343,"twenty":-1.657245,"median":-0.773343,"eighty":-0.326887,"marketCap":6353207},{"date":"2025-03-21","current":-0.856343,"twenty":-1.657245,"median":-0.775465,"eighty":-0.326887,"marketCap":6353207},{"date":"2025-03-28","current":-0.843465,"twenty":-1.657245,"median":-0.777869,"eighty":-0.326887,"marketCap":6257670},{"date":"2025-04-04","current":-0.781666,"twenty":-1.657245,"median":-0.779906,"eighty":-0.326887,"marketCap":5588912},{"date":"2025-04-11","current":-1.102651,"twenty":-1.656913,"median":-0.776375,"eighty":-0.326962,"marketCap":7883954},{"date":"2025-04-17","current":-1.804338,"twenty":-1.658575,"median":-0.776375,"eighty":-0.326962,"marketCap":12901015},{"date":"2025-04-25","current":-1.490249,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":10655283},{"date":"2025-05-02","current":-1.263037,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":9030711},{"date":"2025-05-09","current":-1.202892,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8600677},{"date":"2025-05-16","current":-1.189526,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8505114},{"date":"2025-05-23","current":-1.299601,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8791803},{"date":"2025-05-30","current":-1.440862,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":9747434},{"date":"2025-06-06","current":-1.73751,"twenty":-1.666289,"median":-0.776231,"eighty":-0.326887,"marketCap":11754258},{"date":"2025-06-13","current":-1.751876,"twenty":-1.679146,"median":-0.776231,"eighty":-0.326887,"marketCap":11851440},{"date":"2025-06-20","current":-1.673857,"twenty":-1.686968,"median":-0.776088,"eighty":-0.326811,"marketCap":11323643},{"date":"2025-06-27","current":-1.567468,"twenty":-1.686968,"median":-0.776088,"eighty":-0.326811,"marketCap":10603920},{"date":"2025-07-03","current":-1.702227,"twenty":-1.691978,"median":-0.776088,"eighty":-0.326811,"marketCap":11515569},{"date":"2025-07-11","current":-1.734144,"twenty":-1.707909,"median":-0.776088,"eighty":-0.326811,"marketCap":11731486},{"date":"2025-07-18","current":-1.723505,"twenty":-1.719261,"median":-0.776088,"eighty":-0.326811,"marketCap":11659514},{"date":"2025-07-25","current":-1.780246,"twenty":-1.733339,"median":-0.776088,"eighty":-0.326811,"marketCap":12043366},{"date":"2025-08-01","current":-1.688042,"twenty":-1.737582,"median":-0.776088,"eighty":-0.326811,"marketCap":11419606},{"date":"2025-08-08","current":-1.595838,"twenty":-1.737582,"median":-0.776088,"eighty":-0.326811,"marketCap":10795846},{"date":"2025-08-15","current":-1.553283,"twenty":-1.734773,"median":-0.776088,"eighty":-0.326811,"marketCap":10507957},{"date":"2025-08-22","current":-1.673165,"twenty":-1.737582,"median":-0.776088,"eighty":-0.326811,"marketCap":11854372},{"date":"2025-08-29","current":-1.600418,"twenty":-1.737582,"median":-0.776088,"eighty":-0.326811,"marketCap":11338965},{"date":"2025-09-05","current":-1.665082,"twenty":-1.737619,"median":-0.77587,"eighty":-0.326736,"marketCap":11797105},{"date":"2025-09-12","current":-1.875238,"twenty":-1.740189,"median":-0.776088,"eighty":-0.326811,"marketCap":13286060},{"date":"2025-09-19","current":-1.705496,"twenty":-1.748297,"median":-0.776088,"eighty":-0.326811,"marketCap":12083442},{"date":"2025-09-26","current":-1.778243,"twenty":-1.758968,"median":-0.776088,"eighty":-0.326811,"marketCap":12598850},{"date":"2025-10-03","current":-1.931818,"twenty":-1.768898,"median":-0.776088,"eighty":-0.326811,"marketCap":13686932},{"date":"2025-10-10","current":-1.90757,"twenty":-1.784533,"median":-0.776088,"eighty":-0.326811,"marketCap":13515130},{"date":"2025-10-17","current":-1.713579,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":12140710},{"date":"2025-10-24","current":-1.729745,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":12255245},{"date":"2025-10-31","current":-1.665082,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":11797105},{"date":"2025-11-07","current":-1.196272,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":8475590},{"date":"2025-11-14","current":-1.155858,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":8189252},{"date":"2025-11-21","current":-1.610671,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":12809669},{"date":"2025-11-28","current":-1.705417,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":13563179},{"date":"2025-12-05","current":-1.827232,"twenty":-1.794418,"median":-0.776088,"eighty":-0.326811,"marketCap":14531977},{"date":"2025-12-12","current":-1.542996,"twenty":-1.789969,"median":-0.776088,"eighty":-0.326811,"marketCap":12271447},{"date":"2025-12-19","current":-1.434716,"twenty":-1.789969,"median":-0.776088,"eighty":-0.326811,"marketCap":11410293},{"date":"2025-12-26","current":-1.421181,"twenty":-1.789969,"median":-0.776088,"eighty":-0.326811,"marketCap":11302649},{"date":"2026-01-02","current":-1.421181,"twenty":-1.789969,"median":-0.776088,"eighty":-0.326811,"marketCap":11302649},{"date":"2026-01-09","current":-1.610671,"twenty":-1.778889,"median":-0.776088,"eighty":-0.326811,"marketCap":12809669},{"date":"2026-01-16","current":-1.529461,"twenty":-1.762077,"median":-0.776088,"eighty":-0.326811,"marketCap":12163803},{"date":"2026-01-23","current":-1.461786,"twenty":-1.755984,"median":-0.776088,"eighty":-0.326811,"marketCap":11625582},{"date":"2026-01-30","current":-1.380575,"twenty":-1.745955,"median":-0.776088,"eighty":-0.326811,"marketCap":10979716},{"date":"2026-02-06","current":-1.159683,"twenty":-1.737746,"median":-0.776088,"eighty":-0.326811,"marketCap":9222961},{"date":"2026-02-13","current":-1.651276,"twenty":-1.728625,"median":-0.776088,"eighty":-0.326811,"marketCap":13132602},{"date":"2026-02-20","current":-1.542996,"twenty":-1.723505,"median":-0.776088,"eighty":-0.326811,"marketCap":12271447},{"date":"2026-02-27","current":-1.448251,"twenty":-1.713579,"median":-0.776088,"eighty":-0.326811,"marketCap":11517937},{"date":"2026-03-06","current":-1.583601,"twenty":-1.705496,"median":-0.776088,"eighty":-0.326811,"marketCap":12594380},{"date":"2026-03-13","current":-1.669529,"twenty":-1.702227,"median":-0.776088,"eighty":-0.326811,"marketCap":14521562},{"date":"2026-03-20","current":-1.576035,"twenty":-1.691882,"median":-0.776088,"eighty":-0.326811,"marketCap":13708355},{"date":"2026-03-27","current":-1.682885,"twenty":-1.684948,"median":-0.776088,"eighty":-0.326811,"marketCap":14637735}],"updateTime":1774710248509},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHIO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604119571","title":"Phio Pharmaceuticals Corp - Favorable Safety and Tolerability at All Dose Escalations - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2604119571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604119571?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:33","pubTimestamp":1768919639,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0GE:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2604111968","title":"Phio Pharmaceuticals Corp: Safety Data Through Extended Follow-up Period Is Expected to Be Reported in Q2 of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604111968?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:33","pubTimestamp":1768919639,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0GE:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2604111675","title":"Phio Pharmaceuticals Reports 70% Response Rate in PH-762 Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111675","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604111675?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:31","pubTimestamp":1768919468,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. has announced key pathology and safety data from its Phase 1b dose escalation clinical trial evaluating the INTASYL compound PH-762 for the treatment of skin cancer. The trial included 22 patients with cutaneous carcinomas across five dose-escalating cohorts. Results indicate a 70% overall response rate for squamous cell carcinomas , with 10 out of 14 responders achieving complete clearance. The treatment was well tolerated, with no dose-limiting toxicities or clinically relevant treatment-emergent adverse effects reported. Safety data from an extended follow-up period is expected to be reported in the second quarter of 2026. The company is proceeding with the design of follow-on clinical trials based on these findings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL634l2G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2603835369","title":"Phio Pharmaceuticals Showcases INTASYL siRNA Cancer Therapy at Sidoti Micro-Cap Virtual Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2603835369","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603835369?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:45","pubTimestamp":1768484756,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. will participate in the Sidoti Micro-Cap Virtual Investor Conference on January 21-22, 2026. CEO and Chairman Robert Bitterman is scheduled to present an update on the company's proprietary INTASYL siRNA technology and ongoing clinical trial with lead compound PH-762 for the treatment of skin cancers. The presentation will take place on January 22, 2026, at 1:45 PM ET, and the event will also offer one-on-one meetings with investors throughout both days. Registration is free and open to all interested parties.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile  on January 15, 2026, and is solely responsible for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL3dWCn3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2600736098","title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2600736098","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600736098?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:06","pubTimestamp":1767387968,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President, and CEO of Phio Pharmaceuticals Corp., has reported the acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL2qrg3S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2595780016","title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595780016","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595780016?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:10","pubTimestamp":1767013852,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President, and CEO of Phio Pharmaceuticals Corp., reported the acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDLcdV9zB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2593576413","title":"Phio Pharmaceuticals Corp - No Dose-Limiting Toxicities in Ph-762 Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2593576413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593576413?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:53","pubTimestamp":1766498016,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0MI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2593413669","title":"Phio Pharmaceuticals Corp - Ph-762 Has Been Well Tolerated in All Enrolled Patients in Each Escalating Dose Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593413669?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:53","pubTimestamp":1766498016,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0MI:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2593413501","title":"Phio Pharmaceuticals Corp - Initiatives Continuing to Advance Delivery of Commercially Viable Drug Product in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593413501?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:53","pubTimestamp":1766498016,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0MI:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2593413393","title":"Phio Pharmaceuticals Announces FDA Acceptance of Nonclinical Study Design for PH-762","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413393","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593413393?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:46","pubTimestamp":1766497587,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. has announced a significant advancement in its drug development program for PH-762. The U.S. Food and Drug Administration  has accepted the design of a nonclinical toxicology study, which is required prior to initiating a human pivotal trial. The study is scheduled to commence in the first quarter of 2026. Additionally, Phio is on track to deliver a commercially viable drug product from its U.S. supplier later in 2026, in compliance with the FDA's current Good Manufacturing Practices. The results of the nonclinical study have not yet been presented, as the study has not yet begun.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL3mh04z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2586401960","title":"Phio Pharmaceuticals Completes Enrollment for PH-762 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2586401960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586401960?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:27","pubTimestamp":1764106057,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals ( ($PHIO) ) has provided an announcement. On November 25, 2025, Phio Pharmaceuticals announced the completion of patient enrol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/phio-pharmaceuticals-completes-enrollment-for-ph-762-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/phio-pharmaceuticals-completes-enrollment-for-ph-762-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1988902786.USD","LU1989772840.SGD","BK4580","LU0208291251.USD","LU0070302665.USD","LU2264538146.SGD","BK4585","LU0211331839.USD","BK4139","LU0417517546.SGD","BK4161","PHIO","BK4588","LU1989772923.USD","LU0256863811.USD","LU0256863902.USD","PH","LU1064131342.USD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2586477413","title":"Phio Pharmaceuticals Completes Phase 1b Enrollment for PH-762 Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2586477413","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586477413?lang=en_us&edition=fundamental","pubTime":"2025-11-26 00:31","pubTimestamp":1764088261,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. has announced the completion of enrollment in its Phase 1b clinical trial of PH-762, an INTASYL siRNA compound designed to silence the PD-1 gene implicated in various forms of skin cancer. The trial is evaluating the safety and tolerability of neoadjuvant intratumoral PH-762 in patients with cutaneous squamous cell carcinoma , melanoma, and Merkel cell carcinoma. To date, 18 patients have completed treatment across five dose-escalating cohorts. Pathology results for the highest dose cohort are expected in Q1 2026. No dose-limiting toxicities or clinically relevant treatment-emergent adverse effects have been observed so far.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL94q63P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2586491199","title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586491199","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586491199?lang=en_us&edition=fundamental","pubTime":"2025-11-25 01:54","pubTimestamp":1764006880,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President, and CEO of Phio Pharmaceuticals Corp., reported the acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL4sJNYr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2585616852","title":"BRIEF-Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585616852","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585616852?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:44","pubTimestamp":1763675056,"startTime":"0","endTime":"0","summary":"BRIEF-Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC FilingNov 20  - Phio Pharmaceuticals Corp PHIO.O:PHIO PHARMACEUTICALS CORP FILES FOR OFFERING OF UP TO 11.8 MILLION COMMON SHARES BY THE SELLING STOCKHOLDERS - SEC FILINGFurther company coverage: PHIO.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW124:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2585150601","title":"Phio Pharmaceuticals files to sell 11.76M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2585150601","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585150601?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:11","pubTimestamp":1763673071,"startTime":"0","endTime":"0","summary":"The company will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock. Published first on TheFly...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-files-to-sell-11-76m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-files-to-sell-11-76m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2585761157","title":"Phio Pharmaceuticals Corp Files for Offering of up to 11.8 Mln Common Shares by the Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585761157","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585761157?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:07","pubTimestamp":1763672830,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW124:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2584089922","title":"Phio Pharmaceuticals CEO Robert J. Bitterman Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584089922","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584089922?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:48","pubTimestamp":1763574498,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President & CEO of Phio Pharmaceuticals Corp., reported an acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDLqVrvh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phio Pharmaceuticals CEO Robert J. Bitterman Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2584629877","title":"Phio Pharmaceuticals to Present INTASYL siRNA Technology at Advanced Therapies USA Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2584629877","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584629877?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:46","pubTimestamp":1763387160,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. will deliver a podium presentation on its INTASYL siRNA drug technology at the Advanced Therapies USA 2025 Congress, taking place at the Pennsylvania Convention Center in Philadelphia on November 18-19, 2025. The presentation will focus on INTASYL's approach to down-regulating gene expression for cancer treatment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile  on November 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL1LcHVH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2583126315","title":"Phio Pharma Q3 EPS $(0.44) Misses $(0.40) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583126315","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583126315?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:23","pubTimestamp":1763069002,"startTime":"0","endTime":"0","summary":"Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.40) by 10 percent. This is a 71.43 percent increase over losses of $(1.54) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48851032/phio-pharma-q3-eps-0-44-misses-0-40-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","PHIO","NVIW.SI","QLD","QID","USJW.SI",".IXIC","SQQQ","NQmain","PSQ","USAW.SI","TSYW.SI","BK4139","TQQQ"],"gpt_icon":0},{"id":"2583512597","title":"Phio Pharmaceuticals Reports Positive PH-762 Skin Cancer Trial Results and Extends Cash Runway Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512597","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512597?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:20","pubTimestamp":1763068807,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. announced its third quarter 2025 financial results and provided a business update. The company reported progress in its Phase 1b clinical trial of INTASYL PH-762 for skin cancer, advancing to the fifth and final cohort at the maximum dose. At this dose, one patient achieved 100% tumor clearance , a second patient had greater than 90% tumor clearance , and a third patient showed greater than 50% tumor clearance . No dose-limiting toxicities or clinically relevant treatment-emergent adverse effects were observed, and PH-762 was well tolerated across all dose cohorts. The Safety Monitoring Committee issued a favorable review of safety data at the maximum dose. In addition, Phio completed a warrant inducement financing in November 2025, securing expected net proceeds of approximately $12.1 million, extending the company's cash runway into the first half of 2027. The company also highlighted recent scientific and investor presentations related to its INTASYL siRNA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL34cJm9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}]}}